Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization
- PMID: 9391114
- PMCID: PMC28394
- DOI: 10.1073/pnas.94.25.13838
Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization
Abstract
Cellular immunity is mediated by the interaction of an alphabeta T cell receptor (TCR) with a peptide presented within the context of a major histocompatibility complex (MHC) molecule. Alloreactive T cells have alphabeta TCRs that can recognize both self- and foreign peptide-MHC (pMHC) complexes, implying that the TCR has significant complementarity with different pMHC. To characterize the molecular basis for alloreactive TCR recognition of pMHC, we have produced a soluble, recombinant form of an alloreactive alphabeta T cell receptor in Drosophila melanogaster cells. This recombinant TCR, 2C, is expressed as a correctly paired alphabeta heterodimer, with the chains covalently connected via a disulfide bond in the C-terminal region. The native conformation of the 2C TCR was probed by surface plasmon resonance (SPR) analysis by using conformation-specific monoclonal antibodies, as well as syngeneic and allogeneic pMHC ligands. The 2C interaction with H-2Kb-dEV8, H-2Kbm3-dEV8, H-2Kb-SIYR, and H-2Ld-p2Ca spans a range of affinities from Kd = 10(-4) to 10(-6)M for the syngeneic (H-2Kb) and allogeneic (H-2Kbm3, H-2Ld) ligands. In general, the syngeneic ligands bind with weaker affinities than the allogeneic ligands, consistent with current threshold models of thymic selection and T cell activation. Crystallization of the 2C TCR required proteolytic trimming of the C-terminal residues of the alpha and beta chains. X-ray quality crystals of complexes of 2C with H-2Kb-dEV8, H-2Kbm3-dEV8 and H-2Kb-SIYR have been grown.
Figures
References
-
- Zinkernagel R M, Doherty P C. Nature (London) 1974;248:701–702. - PubMed
-
- Jameson S C, Hogquist K A, Bevan M J. Annu Rev Immunol. 1995;13:93–126. - PubMed
-
- Alam S M, Travers P J, Wung J L, Nasholds W, Redpath S, Jameson S C, Gascoigne N R. Nature (London) 1996;381:616–620. - PubMed
-
- Heath W R, Hurd M E, Carbone F R, Sherman L A. Nature (London) 1989;341:749–752. - PubMed
-
- Sherman L A, Chattopadhyay S. Annu Rev Immunol. 1993;11:385–402. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
